↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Germany TED / Vergabe.de contract award · ocds-ted-330176-2025

Germany – Pharmaceutical products – Vereinbarung nach § 130a Abs. 8 SGB V i. V. m. § 130c Abs. 1 SGB V zum Wirkstoff Bev

AOK Baden-Württemberg Hauptverwaltung awarded €221K to Outlook Therapeutics Limited for Healthcare & Medical in May 2025 — one of 299 awards this buyer has made, in line with its typical award size.

Healthcare & Medical
22 May 2025
Award date
€221K
Contract value

Buying agency

AOK Baden-Württemberg Hauptverwaltung
299 Awards
€256K Avg award
Typical vs typical

Winning supplier

Outlook Therapeutics Limited
2 Awards
2 Buyers
€221K Total won

Contract description

Germany – Pharmaceutical products – Vereinbarung nach § 130a Abs. 8 SGB V i. V. m. § 130c Abs. 1 SGB V zum Wirkstoff Bevacizumab gamma (Lytenava™)

Premium

Related awards · AOK Baden-Württemberg Hauptverwaltung

299 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

255 more awards from this buyer · full history & CSV export

Premium

Other wins · Outlook Therapeutics Limited

2 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for AOK Baden-Württemberg Hauptverwaltung and Outlook Therapeutics Limited — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up